These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Indirect evidence for the efficacy of methotrexate in diffuse systemic sclerosis. Low AH; Lee P J Rheumatol; 2008 Nov; 35(11):2286. PubMed ID: 19004063 [No Abstract] [Full Text] [Related]
27. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. Silver RM; Warrick JH; Kinsella MB; Staudt LS; Baumann MH; Strange C J Rheumatol; 1993 May; 20(5):838-44. PubMed ID: 8336309 [TBL] [Abstract][Full Text] [Related]
28. Optimization of autologous stem cell transplantation for systemic sclerosis -- a single-center longterm experience in 26 patients with severe organ manifestations. Henes JC; Schmalzing M; Vogel W; Riemekasten G; Fend F; Kanz L; Koetter I J Rheumatol; 2012 Feb; 39(2):269-75. PubMed ID: 22247352 [TBL] [Abstract][Full Text] [Related]
29. Clinical images: Voluminous ectopic tumoral calcinosis of the spine in systemic sclerosis. Durant C; Farge-Bancel D Arthritis Rheum; 2011 Feb; 63(2):411. PubMed ID: 20890973 [No Abstract] [Full Text] [Related]
30. Interstitial lung disease associated with systemic sclerosis: what is the evidence for efficacy of cyclophosphamide? Bérezné A; Valeyre D; Ranque B; Guillevin L; Mouthon L Ann N Y Acad Sci; 2007 Sep; 1110():271-84. PubMed ID: 17911442 [TBL] [Abstract][Full Text] [Related]
31. [Long-term clinical-dispensary treatment of patients with systemic scleroderma]. Grinberg NB; Ivanova AV Ter Arkh; 1976; 48(6):115-9. PubMed ID: 973177 [No Abstract] [Full Text] [Related]
32. Scleroderma lung disease: "if you don't know where you are going, any road will take you there". Strange C; Seibold JR Am J Respir Crit Care Med; 2008 Jun; 177(11):1178-9. PubMed ID: 18487619 [No Abstract] [Full Text] [Related]
34. Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis. van Laar JM; Farge D; Tyndall A Ann Rheum Dis; 2005 Oct; 64(10):1515. PubMed ID: 16162905 [No Abstract] [Full Text] [Related]
35. Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital. Joven BE; Almodovar R; Carmona L; Carreira PE Semin Arthritis Rheum; 2010 Feb; 39(4):285-93. PubMed ID: 19782387 [TBL] [Abstract][Full Text] [Related]
36. [Cyclophosphamide pulse therapy for pediatric systemic sclerosis]. Iwata N; Miyamae T; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S; Kondo M; Sasaki T; Ikezawa Y Ryumachi; 2003 Oct; 43(4):660-6. PubMed ID: 14598659 [TBL] [Abstract][Full Text] [Related]
37. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study. Wanchu A; Suryanaryana BS; Sharma S; Sharma A; Bambery P Int J Rheum Dis; 2009 Sep; 12(3):239-42. PubMed ID: 20374353 [TBL] [Abstract][Full Text] [Related]
38. Mandibular function is severely impaired in systemic sclerosis patients. Ferreira EL; Christmann RB; Borba EF; Borges CT; Siqueira JT; Bonfa E J Orofac Pain; 2010; 24(2):197-202. PubMed ID: 20401358 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic interventions in systemic sclerosis. van den Hoogen FH Neth J Med; 1998 Sep; 53(3):137-8. PubMed ID: 9803147 [No Abstract] [Full Text] [Related]
40. Elevated levels of leukotriene B4 and leukotriene E4 in bronchoalveolar lavage fluid from patients with scleroderma lung disease. Kowal-Bielecka O; Distler O; Kowal K; Siergiejko Z; Chwiećko J; Sulik A; Gay RE; Łukaszyk AB; Gay S; Sierakowski S Arthritis Rheum; 2003 Jun; 48(6):1639-46. PubMed ID: 12794832 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]